https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 The effects of tetrahydrocurcumin compared to curcuminoids on human platelet aggregation and blood coagulation in vitro (letter) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36679 Thrombosis Research, Vol. 179, p. 28-30.]]> Tue 23 Jun 2020 15:03:42 AEST ]]> Circulating microvesicles are less procoagulant and carry different miRNA cargo in myelodysplasia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42910 Tue 06 Sep 2022 15:49:23 AEST ]]> Circulating microvesicle number, function and small RNA content vary with age, gender, smoking status, lipid and hormone profiles https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34451 Tue 03 Sep 2019 18:26:31 AEST ]]> A systematic review and meta-analysis comparing anticoagulation versus no anticoagulation and shorter versus longer duration of anticoagulation for treatment of isolated distal deep vein thrombosis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34050 Thu 28 Oct 2021 13:03:25 AEDT ]]> Correlative analysis of nanoparticle tracking, flow cytometric and functional measurements for circulating microvesicles in normal subjects https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27930 s, was -0.34 and -0.30 respectively, p<0.05) and positively correlated with the ELISA MP-activity assay (rs=0.42 for both, p<0.05). In addition, endothelial MV levels weakly correlated with white cell counts (rs = 0.27, p<0.05). Conclusions Thrombin generation and flow cytometry for phosphatidylserine or tissue factor expressing MV correlate well as markers for procoagulant activity. A combination of optical or non-optical enumeration as well as functional methods may be required for a complete profiling of circulating MV.]]> Sat 24 Mar 2018 07:36:09 AEDT ]]>